Evolus, Inc. (EOLS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$6.75
+3.61%
Mkt Cap $439.25M
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (8 analysts)
$15.00
Range $13.00 – $17.00
Implied Upside
+122.4%
Consensus $15.00 vs current $6.75